{"entity":{"id":"nct06771219","kind":"trial","name":"SLV-154 Treatment of Advanced Cancers","aka":[],"tldr":"A phase 1 trial of SLV-154 run by Solve Therapeutics, now recruiting.","summary":"SLV-154 Treatment of Advanced Cancers is a phase 1 interventional study registered as NCT06771219 by Solve Therapeutics, with 250 participants planned, started 2025-05-14. Conditions recorded: Advanced Cancer, Advanced Solid Tumor and Metastatic Cancer. Interventions recorded: SLV-154.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06771219","url":"https://clinicaltrials.gov/study/NCT06771219"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["slv-154"],"companies":["solve-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06771219","phase":"1","setting":"A Phase 1 Dose-Escalation/Expansion Study of SLV-154 in Subjects With Advanced Cancers","sponsor":"Solve Therapeutics","enrolled":250,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06771219/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"slv-154","kind":"drug","name":"SLV-154","route":"/drugs/slv-154/"}],"company":[{"id":"solve-therapeutics","kind":"company","name":"Solve Therapeutics","route":"/companies/solve-therapeutics/"}]}}